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Direct Visualization of Formylpeptide Receptor Binding
on Rounded and Polarized Human Neutrophils:
Cellular and Receptor Heterogeneity
Robert J. Walter and Wayne A. Marasco
Department of Anatomy, University of Illinois at Chicago, Chicago (R.J.W.) and Departments of
Pathology and Internal Medicine, University of Michigan Medical School, Ann Arbor (W.A.M.)
We have used light microscope autoradiography to visualize binding of the formylhexa.
peptide, N-formyl-norleucyl-leucyl-phenylalanyl-norleucyl-(1251)tyrosyl-Iysine to rounded
and spontaneously polarized human polymorphonuclear leukocytes. These cells pos-
sess receptors known to bind with high specificity and great avidity to the chemotactic
formylpeptides. Cells adherent to glass slides were exposed to (1251)-hexapeptide at 4#{176}C,
fixed, and autoradiographed. Hexapeptide binding was studied over the biologically
active range of peptide concentrations varying from 0.63 nM to 10 nM and autoradio-
graphic silver grains counted on 200 rounded or 50 polarized cells at each concentration.
Examination of histograms plotted from these data revealed for rounded cells: 1 ) two
major peaks at each concentration indicating the existence of two neutrophil subpopu-
lations, the predominant subpopulation binding one-half as much formylpeptide (peak I)
as the other (peak II); 2) progressively increasing proportions of cells in peak II as the
free hexapeptide concentration increased. Accordingly, at 0.63 nM hexapeptide, peak II
comprised only 8% of the total cell number, whereas at 10 nM this peak represented
35% of the total cells. This suggested that different types of receptors may exist In the
two cell subpopulations (high/low affinity or high/low negative cooperatlvlty) and that
these receptor types were expressed differentially on these subpopulations. Thus, ccl-
lular heterogeneity within the neutrophil population and receptor heterogeneity among
hexapeptide receptors on an individual cell were both observed here. Each of these may
significantly affect neutrophil functional responses to the chemotactic formylpeptides
and may explain, at least in part, the curvilinearity in the Scatchard plots of formylpep-
tide receptor binding that has recently been reported.
At higher concentrations of peptide ( 5 nM), spontaneously polarized PMN bound
hexapeptide more or less uniformly over the entire cell surface. However, at lower
concentrations, hexapeptide binding was markedly shifted toward the cell anterior. As a
group, polarized PMN bound similar total quantities of hexapeptide, as did rounded PMN
at each peptide concentration tested. Receptors displaying high. and low-affinity char-
acteristics were, however, distributed asymmetrically over the cell surface, with the
high-affinity type receptors predominantly on the anterior one-half of the cell. Such an
asymmetric distribution may serve to initiate or perpetuate cell locomotion.
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INTRODUCTION
Polymorphonuclear leukocytes (PMN) are highly
phagocytic components of the immune system that re-
spond chemokinetically and chemotactically to soluble
bacterial factors [4,27,41]. PMN must continually moni-
tor and respond to such soluble chemotactic stimuli in
order to detect concentration gradients of soluble factors
and also to initiate and to perpetuate stimulated and direc-
tional locomotion. These activities are mediated by cell
surface receptors that bind certain specific classes of
chemotactic molecules [34,42]. Among these factors are
the naturally occurring formylmethionylpeptides [2,55],
a group of molecules now known to be the NH2-terminal
post-translational clip products of nascent bacterial pro-
teins as well as bacterial signal peptides. Purified syn-
thetic analogues of these naturally occurring bacterial
substances are also potent leukocyte chemoattractants
[21,24,41,42].
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In the past, suspensions of PMN isolated from any
given individual were considered to be rather homoge-
neous with respect to chemoattractant binding. However,
this notion must be reassessed in light of recent evidence
that PMN populations are quite heterogeneous [6,7,
8, 10,35,37]. Subpopulations of leukocytes have been re-
ported, each of which expresses its own characteristic
number of receptors for formylpeptide chemoattractants.
In addition, recent findings suggest that PMN receptors
for formylpeptides and those for leukotriene B4 may also
express more than one binding affinity for ligand
[9, 17, 19,36,40]. Such heterogeneity within the PMN
population and among the formylpeptide receptors them-
selves has been shown indirectly, using receptor-binding
kinetics or flow cytometry. Using these techniques, it has
only recently been possible to determine that cell hetero-
geneity and formylpeptide receptor heterogeneity coexist
within the same population of cells [23]. We have dem-
onstrated both types of heterogeneity in populations of
human PMN binding the formylpeptide chemoattractant,
formyl-norleucyl-leucyl-phenylalanyl-norleucyl-(’ 251)ty-
rosyl-lysine. This heterogeneity has been visualized di-
rectly using light microscope autoradiographic methods.
Our results indicate that both cell and receptor binding
heterogeneity occur simultaneously in populations of hu-
man PMN.
Several types of membrane receptors exhibit inherent
anteroposterior asymmetric distributions on the cell sur-
face of motile leukocytes [38,47,50-53]. Such asymme-
tries may facilitate motility-related activities such as
phagocytosis, receptor-mediated endocytosis, and chem-
otaxis in these cells. Transcellular asymmetries of for-
mylpeptide receptors across the cell surface of rounded
or polarized PMN might play a significant role in modu-
lating the cell’s initial or continued response to chemotac-
tic stimuli. We have examined the occurrence and
distribution of hexapeptide receptors on the surface of
spontaneously polarized PMN using a range of hexapep-
tide binding concentrations. At high binding concentra-
tions ( 5 nM), hexapeptide was found to bind more or
less uniformly over the entire cell surface. However, at
lower concentrations ( 2.5 nM), hexapeptide bound
asymmetrically, predominantly over the anterior half of
polarized PMN.
MATERIALS AND METHODS
Isolation of Human Peripheral PMN
Whole peripheral blood drawn from healthy volunteers
into tubes containing EDTA was allowed to undergo
gravity sedimentation for 45 mm at room temperature.
The leukocyte-rich plasma was drawn off and then di-
luted 1:1 with buffer containing 140 mM NaCl, 10 mM
KCI, 10 mM HEPES, 5 mM glucose, and 2 mg/mi
bovine serum albumin, pH 7.4 (HBS). This suspension
was gently layered onto 1 ml of lymphocyte separation
medium (Bionetics, Kensington, MD), and the discontin-
uous gradient centrifuged at 500 x g for 5 mm in a
clinical centrifuge. The supernatant was aspirated, the
cell pellet resuspended in HBS containing 2 mM EDTA,
and this suspension centrifuged momentarily in an Ep-
pendorf centrifuge. Erythrocytes in the cell pellet were
lysed by hypotonic shock and the PMN rinsed three times
in HBS containing EDTA. Cells were then stored at 4#{176}C
until use. Cell preparations contained more than 95%
polymorphonuclear leukocytes, with the remaining cells
being predominantly eosinophils [50,51].
Exposure to lodinated Hexapeptide
PMN suspended in 25 j.il HBS containing 1 mM MgSO4
and 0.2 mM CaCI2 were placed onto acid-cleaned glass
microscope slides in a humidified chamber for 5 mm at
37#{176}C.Subsequently, 25 jl of (‘251)-labeled hexapeptide
(2,000 Ci/mmole) in the same buffer was added to each
slide and the slides with adherent cells incubated further
at 4#{176}Cfor 15 mm. N-formyl-norleucyl-leucyl-phenyl-
alanyl-norleucyl-tyrosyl-lysine (Peninsula Laboratories,
Belmont, CA) was iodinated at the tyrosine position us-
ing carrier-free 1125 by the chloramine-T method as de-
scribed previously [13-15, 22]. The binding charac-
teristics (i.e. , saturation curves, reversibility of binding,
equilibrium conditions) of this probe have been reported
previously [28]. The final concentrations of (1251)-hexa-
peptide used were 10 nM , 5 nM , 2 .5 nM, 1 .25 nM , and
0.63 nM. In addition, control experiments for nonspe-
cific binding were performed in which unlabeled hexa-
peptide (1 ,000-fold excess) was added simultaneously
with iodinated hexapeptide. Upon completion of this in-
cubation, all slides and adherent PMN were rinsed
quickly in two changes of HBS and once in HBS lacking
bovine serum albumin. Slides were then submerged in
cold fixative solution containing 1.5% glutaraldehyde,
1.0% paraformaldehyde, and 0.1 M cacodylate, pH 7.2.
Autoradiography and Sampling Procedures
Cells were fixed overnight, rinsed in 0.1 M cacodylate
buffer, in Dulbecco’s modified Eagle’s medium, in cac-
odylate buffer again, and then dehydrated in graded
ethanols to 80% ethanol. Cells were then rehydrated, and
slides were dipped in Kodak NTB-2 emulsion (diluted
1:5 with distilled water), air dried, and stored for 3 days
at 4#{176}Cin the dark. Exposed autoradiographs were devel-
oped using Kodak D-19, fixed, stained in eosin and cresyl
violet, and coverglasses affixed using Permount
[52]. Localization of radioactive sources by this method
was generally good, with the great majority of exposed
silver grains lying very close to the cell surface (within 1
/2m) [5,32]. Grains overlying the cell contours seen by
phase contrast were counted, whereas grains lying more
than 1 m outside this profile were considered to be
background and not cell associated.
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Cells were examined and photographed using a Nikon
Optiphot microscope equipped with an Olympus OM-2n
camera. Phase-contrast optics were used to determine
cell morphology and dark-field optics to visualize and
count silver grains associated with the cells. For recep-
tor-binding studies on rounded PMN, grains associated
with 200 cells were counted for each experimental group.
Three experiments were performed and duplicate slides
were run for each hexapeptide concentration.
Polarized cells were identified using phase contrast
optics and their overall length measured using an eye-
piece reticle. This length was halved and the micrometer
line corresponding to this midpoint used to distinguish
the anterior or front half of the cell from the posterior or
rear half of the cell. This midpoint was usually found to
lie at the posterior boundary of the nucleus. Grains over
each half of the PMN were counted and the ratio of
grains on the front:rear of the cells calculated. Fifty
polarized cells in each group were assessed, three sepa-
rate experiments were performed, and duplicate slides
were run for each hexapeptide concentration.
Our method for dividing PMN into anterior and pos-
tenor halves was based upon the spatial sensing hypoth-
esis for chemotaxis [1,27,34]. According to this model,
cells sense concentration gradients of chemoattractants
by differential occupancy of receptors across the cell
surface. Thus, the distance from the leading edge to the
trailing uropod tip may well affect the cell’s capacity to
sense a concentration gradient or to respond appropri-
ately to a chemotactic factor [3 1] . Since the anteroposte-
nor distance may be a physiologically significant param-
eter, our division of PMN simply into anterior and pos-
terior halves should provide some measure of this
parameter.
This method does not compensate for possible differ-
ences in the amount of plasma membrane, in organelle
distributions within the PMN, or possible differences in
adhesion between the front and rear of these cells. Al-
though such factors are undoubtedly important in initiat-
ing and perpetuating chemokinesis and chemotaxis
[42,43,45,46], their exact significance in these activities
is unproven. Nevertheless, this method was expeditious
and provided useful information without exceeding the
resolution of the autoradiographic technique [5,32,52].
Statistical Analyses
For rounded PMN, frequency distribution histograms
were generated from these grain counts (using ABSTAT,
Anderson-Bell’s statistics package), with the abscissa
representing the amount of hexapeptide bound to individ-
ual cells within the leukocyte population and the ordinate
representing the number of frequency of cells in the
population exhibiting a given level of hexapeptide bind-
ing. These histograms were then analyzed using PEAK-
FIT (EMF Software, Knoxville, TN). This program fits
data to one or multiple Gaussian peaks by a non-linear
least-squares method using the Simplex algorithm. The
number of population means, their values, and variances
were first approximated by eye from the frequency dis-
tribution to establish a starting point for the fit. The
program then defined the normal curve(s) that most
closely fit the experimental data. Usually 100-300 curve
fining operations and refinements were required for the
program to obtain the closest fit. Goodness of fit for
single or multiple peaks, mean values, standard devia-
tions, and peak areas were calculated; F tests comparing
the fit for distributions having one or two peaks were
performed using PEAKFIT [25,26].
For polarized cells, grains were counted on the front
and rear halves of 50 cells at each hexapeptide concentra-
tion. These values were then compared using paired t-
tests. The ratio of grains on the front: rear halves of cells
exposed to 10 nM iodinated hexapeptide was calculated.
This ratio was then compared to similar ratios calculated
for polarized cells exposed to other concentrations of
hexapeptide using the Mann-Whitney U-test. In addition,
the total number of grains counted on polarized cells at
each concentration of iodinated hexapeptide was com-
pared to that obtained for rounded cells at these same
concentrations using chi-square.
RESULTS
Receptor Saturation Experiments: Rounded Cells
Human PMN exposed to (I’25)-labeled hexapeptide
bound substantial amounts of peptide to their cell surface
(Figs. 1, 2). The silver grain counts seen after 3 days
exposure ranged from an average of 7. 8 grains/cell at
0.63 nM iodinated hexapeptide to 41 .2 grains/cell at 10
nM iodinated hexapeptide. Nonspecific binding of hexa-
peptide plus emulsion background silver grains never
exceeded an average of 0.6 grains/cell (i.e., 2-8% of
total). Figure 3 shows a saturation curve of the data
obtained from these experiments. As can be seen, bind-
ing approached saturation at high hexapeptide concentra-
tions such that an overall 16-fold increase in hexapeptide
concentration was accompanied by a 5-fold increase in
hexapeptide binding to PMN. As expected, the rate of
increase in binding was gradually reduced at higher hex-
apeptide concentrations. In individual experiments, a dis-
tinct tendency for large variances in the cell population
with regard to the number of grains per cell was also
noted. However, between experiments the variance was
considerably smaller. As a result, we further examined
individual cells within the population to determine whether
the amount of hexapeptide binding per cell was described
by a normal curve.
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Fig. 1. Light micrographs of rounded, nonmotile human PMN
exposed to 10 nM (a, b) or 5 nM (c, d) (125I)-hexapeptlde for 15
mm at 4#{176}C.ells exposed simultaneously to 10 nM (1251)-hexa-
peptide and 10 LM unlabeled hexapeptide are shown in e and f.
Cell monolayers were viewed using phase-contrast optics (left
column) or dark-field optics (right column) to accentuate the
silver grains. Controls for nonspecific binding and emulsion
background (e, f) are virtually free of silver grains. On the other
hand, many grains are seen overlying cells exposed to 10 nM
labeled formylpeptide (a, b), and somewhat fewer over cells
exposed to 5 nM hexapeptide (c, d). A cell exhibiting a particu-
larly large number of grains is seen in the top panel (a, b)
(arrow). Such cells are characteristic of those found in peak II
of Figure 4. Magnification bar = 10 m.
0
Fig. 2. Phase contrast (left) and dark-field (right) mlcrographs of rounded PMN
exposed to 2.5 nM (a, b), 1.25 nM (c, d), or 0.63 nM (125l)-hexapeptide (e, f). As the
concentration of labeled hexapeptide was decreased, the number of grains over the
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Hexapeptide Binding to PMN in the Sample
Population
The silver grains associated with 200 PMN were
counted for cells exposed to 0.63, 1.25, 2.5, 5.0, or 10
nM (V25)-hexapeptide. Histograms generated from this
data are shown in Figure 4 and summarized in Table 1.
For cells at each binding concentration of iodinated hex-
apeptide, bimodal distributions of hexapeptide binding
clearly emerged. The PEAKFIT program showed that
the fit for two peaks was significantly better in each case
than the fit for a single peak (see Table 1). The relative
numbers of cells in each subpopulation (peaks I and II)
varied, depending on the initial binding concentration of
hexapeptide, but the bimodal character of the curves was
still evident.
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FIg. 3. Saturation plot for hexapeptide binding to human PMN
generated from light microscope autoradiograph grain counts.
The cells were exposed to (‘25l)-hexapeptide for 15 mm at 4#{176}C,
fixed, autoradiographed, and the grains overlying 200 cells
counted. The mean numbers of grains/cell were calculated for
subpopulations seen at each concentration of hexapeptide
(mean ± SD). The means for the subpopulatlon binding larger
amounts of hexapeptide (peak II, A), means for the subpopu-
latlon binding lesser amounts of hexapeptide (peak I, U), and
overall population means (#{149})are shown. Hexapeptide binding
was also assessed in the presence of 1 ,000-fold excess unla-
beled hexapeptide (0).
It seems evident from these data that there are two
distinct subpopulations of PMN within a suspension or
monolayer of cells. The ratio of the mean grain counts
per cell for the two PMN subpopulations seen is more or
less constant at about 0.50. One of these subpopulations
seems to bind approximately twice as much hexapeptide
as does the other. These two subpopulations seemed to
be distinct and separate in regard to the amount of hexa-
peptide bound, but otherwise they exhibited very similar
saturation characteristics (see Fig. 3). Seligmann et al
[35] have also demonstrated the occurrence of cellular
heterogeneity using flow cytometry. In their study, about
40% of the PMN population displayed membrane depo-
larization in the presence of formyl-methionyl-leucyl-
phenylalanyl-lysine, and this subpopulation showed about
25 % more formylpeptide binding than the nonresponding
subpopulation. At 10 nM hexapeptide, we saw 35% of
the PMN population binding about 100% more hexapep-
tide. Differences in experimental conditions (notably,
temperature and length of time allowed for binding) may
account for this discrepancy.
Furthermore, the proportion of cells in each peak var-
ied depending on the initial concentration of hexapeptide
present during binding. PMN from the subpopulation
having more binding per cell (peak II) comprised 8% of
the total population at 0.63 nM (25I)-hexapeptide, 15%
at 1.25 nM, 18% at 2.5 nM, 21% at 5 nM, and 35% at
10 nM. This progression of increasing cell frequencies
may indicate that the cells in peak II are expressing a
different type of binding site for hexapeptide, which is
only expressed fully as the hexapeptide concentration is
increased toward saturation. One possibility in this re-
gard is that receptors having different affinities or a
single receptor having high- and low-affinity states might
exist (see Fig. 5). The aforementioned similarities in the
saturation characteristics of both subpopulations might




Grains/cell (mean ± SEM)0 Ratio of means
(peak I/peak II) P’Peak I (%) Peak II (%)
10 34.5 ± 5.5 (65)b 64.1 ± 3.7 (35) 0.54 <.005
5 22.0 ± 3.4 (79) 42.7 ± 2.5 (21) 0.52 <.0001
2.5 15.9 ± 2.9 (82) 32.6 ± 2.8 (18) 0.49 <.05
1.25 12.3 ± 2.1 (85) 25.6 ± 1.8 (15) 0.48 <.03
0.63 7.2 ± 1.2 (92) 15.3 ± 0.5 (8) 0.47 <.04
aGrains associated with 200 cells were counted at various concentrations of (‘251)-hexapeptide. Using these grain counts,
histograms were generated using ABSTAT, and these frequency distributions were analyzed using PEAKFIT computer
analysis. Two subpopulations of PMN were demonstrated at each concentration of labeled hexapeptide tested. For details
of these procedures see Materials and Methods section.
bThe percentage of the total cells in each subpopulation.
cComparison of F ratios (from PEAKFIT) for experimental population distribution with theoretical normal distribution
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Fig. 4. Histograms showing the frequency of cells and the
amount of hexapeptide bound by cells (grains/cell) exposed to
different concentrations of (‘25l)-hexapeptide. Two hundred
cells were counted, and they appear to fall Into two subpopu-
lations. At 10 nM hexapeptide (a), one subpopulation has a
mean of 35.5 (peak I) and the other a mean of 64.1 (peak II)
grains/cell (arrows). At 5 nM (125l)-hexapeptide (b), a prominent
peak or subpopulation having a mean of 22.0 and a smaller
subpopulation having a mean of 42.7 grains/cell are evident
(arrows). At 2.5 nM (1251)-hexapeptide (c), the predominant sub-
population of cells shows a mean grain count of 15.9, while the
tend to favor this latter interpretation. On the other hand,
Marasco et al [23] have demonstrated negative coopera-
tivity among the formylpeptide receptors of rat [neutro-
phil plasma membranes and on whole rat neutrophils
Marasco, W.A., Feltner, D.E., and Ward, P.A., unpub-
lished results]. Heterogeneity in the expression of such
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B
smaller subpopulation displays a mean grain count of 32.6
grains/cell (arrows). For cells exposed to 1.25 nM (125l)-hexa-
peptide during binding (d), approximately 85% of the popula-
tion is found in a subpopulation having a mean grain count of
12.3, while the remaining cells is In a subpopulation having a
mean grain count of 25.6 grains/cell (arrows). For cells exposed
to 0.63 nM (‘25l)-hexapeptide (e), only 8% of the population
remained in the second peak with a mean grain count of 15.3
grains/cell. Ninety-two percent of the PMN were found in the
other subpopulation and the mean number of grains associated
with these cells dropped to 7.2 grains/cell (arrows).
the progressively decreasing cell frequencies seen here.
Accordingly, it might be argued that cells in peak II
express little receptor negative cooperativity relative to
cells found in peak I.
The morphological appearance of PMN from both sub-
populations (peak I and peak II) was also compared (see
Fig. 1). There was some variation in the relative degree
RECEPTOR AFFINITY
A) Two Distinct Receptors
B) Altered Receptor Conformation
NEGATIVE COOPERATIVITY
C) Inherent Receptor Clustering
EJ _
D)Altered Membrane Conformation
fl High-Affinity Hexapeptide Receptor
(or low negative cooperativity)
J Low-Affinity Hexapeptide Receptor
(or high negative cooperativity)
Hexapeptide
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Fig. 5. Schematic representation of possible mechanisms for
receptor heterogeneity in human PMN. When binding occurs at
a given hexapeptide concentration (e.g., 10 nM), some recep-
tors may bind peptide avidly (right column) while others bind it
poorly (left column). Such heterogeneity is generally attributed
to the occurrence of receptors having either different affinities
(a, b) or different degrees of destabilizing interactions, that is,
negative cooperativity (d). Differences in receptor affinities may
be generated as a result of either the existence of two distinctly
different receptors each with different affinities for hexapep-
tide (a) or perturbations of a single receptor type by some
outside Influence (b) altering its hexapeptide binding capacity.
On the other hand, destabilizing receptor interactions may af-
fect hexapeptide binding even to a single class of hexapeptide
receptors. Such receptor-receptor interactions might become
significant when receptors lie in close proximity to one an-
other. These destabilizing conditions might occur as the result
of inherent receptor clustering (C) or plicated, Irregular mem-
brane conformations (d) existing locally on the cell surface.
of cell flattening and in the nuclear stain intensity
throughout the PMN population, but these differences
did not seem to correlate with differences in the hexapep-
tide binding. No differences in the sizes of the cells or in
the nuclear morphology between the two groups were
observed. Thus, cells in each of the two subpopulations
showed no morphologic differences correlating with the
observed differences in hexapeptide binding (a cell from
peak II is seen in Fig. I at arrow).
Hexapeptide Distribution on Polarized PMN
PMN exposed to (‘25I)-hexapeptide at 4#{176}Cfor 15 mm
were studied to determine the distribution of silver grains
on spontaneously polarized or motile cells. Many silver
grains were seen on cells exposed to 10 nM hexapeptide,
and the grains seemed to be distributed somewhat uni-
formly on the cell surface of polarized PMN (Fig. 6a,
b). Fewer grains were seen on cells exposed to 5 nM
hexapeptide, but the grains were still distributed some-
what uniformly over the entire cell surface (Fig. 6c, d).
However, as the concentration of iodinated hexapeptide
was decreased further, the distributiopn of grains shifted.
Cells exposed to 2.5 nM (125I)-hexapeptide displayed
grains predominantly over the anterior half of the cell
(Fig. 7a, b). At lower concentrations of hexapeptide
(Fig. 7c-f) this same phenomenon became more appar-
ent. Increasingly, receptors occurred on the front half of
each cell, while fewer appeared on the rear half. The
numbers of nonspecific and background grains were al-
ways very low (Figure 7g, h).
Grain counts performed on polarized PMN are seen in
Table 2. Polarized cells exposed to 0.63, 1.25, 2.5, 5, or
10 nM (I’25)-hexapeptide were studied, and grains on the
front and rear halves of each cell were counted as de-
scribed in the Methods section. Fifty cells were studied
in each group for each experiment, and three experiments
were performed. At 5 and 10 nM concentrations, PMN
exhibited a slight anterior tendency in their distribution
of hexapeptide binding sites. As a result, the ratio of
grains counted on the front : rear of these cells was slightly
elevated (1 .41 for cells at 10 nM and 1 .37 for cells at 5
nM). At lower concentrations of hexapeptide, however,
a much greater anteriorward shift in the distribution of
grains on polarized PMN occurred. Cells exposed to
0.63, 1,25, or 2.5 nM hexapeptide bound less peptide,
of course, but the ratio of grains seen on the front:rear
of these cells was dramatically increased (2.86 at 2.5
nM, 3.33 at 1.25 nM, and 4.00 at 0.63 nM). The ratios
of grains counted front:rear for cells exposed to 2.5 nM
or less hexapeptide were significantly different (P <
.001, Mann-Whitney U-test) from those obtained for
cells exposed to 5 or 10 nM hexapeptide. In addition,
when the grain counts on the front and rear of cells were
compared, there were statistically significant differences
(P < .002, paired t-tests) seen at each concentration of
peptide used.
In the studies described here, we examined sponta-
neously polarized cells, and these cells were studied
using uniform fields (i.e., not gradients) of the chemoat-
tractant f-Nle-Leu-Phe-Nle-Tyr-Lys. It might be argued
that spontaneously polarized cells are unusual in some
respect and may not represent the population of cells that
are ordinarily stimulated by chemoattractants. These cells
represented less than 4% of the entire PMN population,
C





















Fig. 6. Phase-contrast (left) and dark-field (right) microscopy showing sponta-
neously polarized human PMN (arrows). Cells were exposed to (1251)-labeled hexapep-
tide at 10 nM (a, b), 5 nM (c, d), or at 10 nM in the presence of 10 M unlabeled
hexapeptide (e, f). At both 5 and 10 nM hexapeptide, silver grains appeared over the
entire cell surface, with only a slight tendency toward the anterior of the cell. Cells
exposed to labeled and excess unlabeled hexapeptide showed very few cell-associ-
ated grains. Magnification bar = 10 m.
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TABLE 2. Hexapeptide B inding on Polarized Human PMN
(‘25I)-hexapeptide
concentration (nM)
Grains/cells (mean ± SEM)
Ratio
(15 mm at 4#{176}C) PMN front” PMN rear” (front/rear) ph
10 18.6 ± 2.6 13.2 ± 3.7 1.41 -
5 17.2 ± 2.3 12.6 ± 2.8 1.37 >20
2.5 13.4 ± 1.4 4.7 ± 2.6 2.86 <.001
1.25 8.1 ± 0.8 2.4 ± 1.8 3.33 <.001
0.63 4.8 ± 1.2 1.2 ± 1.4 4.00 <.001
lOnM + 0.2 ± 0.1 0.2 ± 0.1 - -
10 aM cold
hexapeptide
“Polarized PMN were transected with a line between the leading edge and trailing uropod tip. Grains over each half of
the cell were then counted.
Three separate experiments were run: 50 cells were counted for each data point in each experiment.
When the number of grains at the front of each PMN was compared with that at the rear of each PMN using paired t-
tests, values were found to be significantly different at the P <.002 for each concentration of labeled hexapeptide used.
bEach ratio was compared to that calculated for 10 nM hexapeptidc binding concentration using Mann-Whitney U-test.
and the cause for their polarization or apparent motility
is not known. The polarization ofthese cells might reflect
previous stimulation by chemokinetic factors encoun-
tered during cell isolation or substrate adhesion. As a
result, cell surface components such as the formylpeptide
receptor might be redistributed over the cell surface in
response to cell polarization. Similar secondary redistri-
bution and resulting asymmetries of unoccupied recep-
tors have been described previously for Fc and C3b
receptors, and possible mechanisms for their occurrence
have been discussed elsewhere [50,51].
On the other hand, these polarized cells may represent
a small subpopulation of PMN that is particularly sensi-
tive to chemokinetic or chemotactic stimuli. Increased
sensitivity to chemoidnetic activation might result from
an unusually large or small number of receptors for
chemoattractant or an unusual distribution of receptors
on the cell surface. However, it appears that these spon-
taneously polarized cells are not unique with respect to
their total hexapeptide binding. The total amount of hexa-
peptide bound to polarized cells was about the same as
that bound to rounded cells in the general population at
the same hexapeptide concentration (Table 3).
Fig. 7. Phase-contrast (left) and dark-field (right) autoradio-
graphs of cells exposed to (1251)-hexapeptide. PMN were cx-
posed to 2.5 nM (a,b), 1.25 nM (c, d), or 0.63 nM (e, f) iodlnated
hexapeptide, or to 2.5 nM (125l)-hexapeptide with a 1,000-fold
excess of unlabeled hexapeptide (g, h). Polarized cells treated
with 2.5 nM labeled hexapeptide displayed many silver grains
over the anterior half of each cell. Polarized PMN exposed to
either 1 .25 nM (arrow) or 0.63 nM (1251)-hexapeptide exhibited
fewer grains overall, but these grains were distributed predom-
inantly over the anterior half of each cell with very few grains
seen over the uropod region. Magnification bar = 10 m.
DISCUSSION
The results of our experiments using light microscope
autoradiography to quantitate the amount of hexapeptide
binding to human PMN are, in general, very similar to
those obtained by conventional radioligand binding meth-
ods [23 , 28, Walter and Marasco, unpublished data].
However, while data from autoradiographic studies can
be used to generate saturation-type curves for hexapep-
tide binding, it is much more useful for studying the
formylpeptide binding characteristics of individual cells
within the PMN population. Used in this way, certain
aspects of this binding can be studied to great advantage.
Cellular and Receptor Heterogeneity on
Rounded PMN
In the present study, all ligand-receptor interactions
occurred at 4#{176}C,so that any active cellular responses to
hexapeptide binding were greatly diminished or absent.
As a result, inherent binding capacity is demonstrated
such that binding is not a function of ongoing receptor
clustering, membrane perturbation, endocytosis, or exo-
cytosis. Under these conditions, there appear to be two
basic mechanisms (Fig. 5) by which the observed differ-
ences in receptor binding may evolve. 1) Differences in
receptor affinities: such differences might be attributed
to either two entirely distinct receptors having different
affinities (Fig. 5a) or to a single receptor exhibiting two
different conformations (Fig. Sb). 2) Negative coopera-
tivity among receptors: steric interference or other de-
stabilizing interactions might occur among formylpeptide
receptors under certain conditions . Increased inherent
receptor clustering (cross-linking) (Fig. Sc) or certain
membrane configurations (Fig. Sd) could cause poor
accessibility of the peptide receptor or interference in
hexapeptide binding to its receptor.
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TABLE 3. Hexapeptide Bi nding on Rounded and Polarized
Human PMN
(‘25I)-hexapeptide
(15 mm at 4#{176}C)
Grains/cell (mean ± SEM)”
Rounded cells Polarized cells
10 41.3 ± 5.2 31.8 ± 6#{149}7b
5 26.3 ± 3.4 29.8 ± 4.6
2.5 18.8 ± 2.8 18.1 ± 4.0
1.25 14.3 ± 1.8 10.5 ± 2.4
0.63 7.8 ± 1.0 6.0 ± 2.0
10 nM + 10 M cold 0.5 ± 0.2 0.4 ± 0.2
hexapeptide
2.5 nM + 2.5 zM cold 0.6 ± 0.3 0.5 ± 0.2
hexapeptide
0.63 nM + 0.63 zM cold 0.6 ± 0.2 0.6 ± 0.2
hexapeptide
“Total number of silver grains associated with 200 rounded cells or
50 polarized cells were counted. Three separate experiments were
run.
‘l’he mean grain counts calculated for rounded and polarized cells at
each hexapeptide concentration were compared using chi-square.
Values at each concentration were not significantly different.
lOnM HEXAPEPTIDE 0.63 nM HEXAPEPTIDE
fl High-Affinity Hexapeptide Receptor
(or low negative cooperativity)
 Low-Affinity Hexapeptide Receptor
(or high negative cooperativity)
Hexapeptide
Fig. 8. Diagram representing formylhexapeptide receptor dis-
tribution and hexapeptide binding on spontaneously polarized
PMN. High-affinity or low negative cooperativity receptors are
distributed primarily over the anterior half of the polarized cell.
Low-affinity/high negative cooperativity receptors may be dis-
tributed more uniformly or only on the posterior half of the cell.
Thus, at high concentrations of hexapeptide (> 2.5 nM), much
hexapeptide would bind to both the anterior and posterior
halves of the PMN. As the concentration of free chemoattrac-
tant decreased, the amount of hexapeptide binding to the low-
affinity/high negative cooperativity receptors on the posterior
half of the cell would decrease rapidly, while the amount of
hexapeptide binding to the receptors on the anterior half of the
cell would decrease at a comparatively low rate. As a result,
hexapeptide would bind asymmetrically over the PMN cell sur-
face with an Increasing proportion on the anterior half of the
cell.
The occurrence of receptor heterogeneity (high- and
low-affinity binding states or differences in negative co-
operative interactions) for the formylpeptide chemotaxis
receptor may result from the interaction of the cytoskel-
eton with the cell surface (see Fig. Sb). Such interactions
might cause the expression of the high-affinity receptor
state, whereas receptors not interacting with the cyto-
skeleton might remain as low-affinity binding sites for
hexapeptide. Jesaitis et al [15] have described the forma-
tion of high-affinity formylpeptide receptor complexes
associated with detergent-insoluble “cytoskeletons” of
human granulocytes. White et al [54] have shown that
actin becomes associated with such “cytoskeletons” after
cells are stimulated with formylpeptide. However, at pre-
sent, no direct or indirect linkages between the cytoskel-
eton and surface formylpeptide receptors have been
demonstrated.
Populations of PMN are also known to exhibit hetero-
geneity in their rates of locomotion [12], immunoglobulin
G Fc receptor expression and Fc receptor-mediated activ-
ity [16,56], membrane potential responsiveness to for-
mylpeptide [35] , cell density [30] , and cell surface
antigens [3 ,37]. The observed variability or heterogene-
ity in the numbers of receptors expressed by PMN within
the sample population may then have functional signifi-
cance. Certain subpopulations of PMN may be more
effective in detecting or transducing chemotactic stimuli
as a result of the cellular or receptor heterogeneity of
chemotaxis receptors on the cell surface. Consequently,
some PMN may respond to formylpeptide at lower con-
centrations than do other PMN, and this subpopulation
of cells may also exhibit lower thresholds for chemotactic
deactivation or for degranulation.
Receptor Heterogeneity on Polarized PMN
The distribution of hexapeptide bound to polarized
cells differed, depending on the concentration of hexa-
peptide to which the cells were exposed during binding.
At high concentrations, hexapeptide bound to receptors
across the entire cell surface, although with some appar-
ent tendency toward the anterior half of the cell. How-
ever, at lower concentrations, hexapeptide bound pri-
manly to receptors lying on the anterior half of the cell.
These data suggest that high- and low-affinity hexa-
peptide receptors may be expressed asymmetrically on
the surface of spontaneously polarized PMN (see Fig. 8).
High-affinity formylhexapeptide receptors evidently lie
predominantly over the anterior half of polarized cells
and low-affinity receptors mainly over the rear or poste-
rior half of each PMN. Thus at lower hexapeptide con-
centrations (< SnM), hexapeptide would bind pref-
erentially to the front of polarized PMN, whereas at high
hexapeptide concentrations ( S nM) hexapeptide would
bind somewhat more uniformly over the cell surface.
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Studies by Snyderman and co-workers [17,40,57] in-
dicated that the leukocyte formylpeptide receptor may
exist in two partially interconvertible affinity states. The
high-affinity state enhances chemotaxis and depresses
lysosomal enzyme secretion, whereas the low-affinity
state depresses chemotaxis and enhances enzyme secre-
tion. The existence of two such receptor states is entirely
consistent with the data presented here. The conversion
between these two affinity states is apparently regulated
by guanine nucleotides [18] and by agents that alter
membrane fluidity [57] . Fluctuations in local calcium and
cyclic nucleotide levels are also known to occur in PMN
stimulated by chemoattractants [7,39] . Global or local
alterations such as this may affect the affinity of nearby
formylpeptide receptors, inducing the asymmetric distri-
bution of high-affinity receptors described here.
The asymmetric distribution of hexapeptide receptors
described here might aid in directed locomotion by am-
plifying differential transcellular binding occurring in
formylpeptide concentration gradients [11 ,3 1] . It may
promote random or perpetuate directed locomotion by
restricting binding of chemotactic stimuli to a particular
region of the cell surface. This might create apparent
gradients across the cell surface, even without actual
chemical diffusion gradients. In either case, local activa-
tion of the motile apparatus might occur in regions of
increased chemoattractant binding. Formylpeptide bind-
ing to leukocytes is known to induce changes in actin
conformation [49] and in the occurrence and distribution
of microtubules [20,44] . In addition, several cytoskeletal
proteins have been shown to be asymmetrically distrib-
uted in polarized leukocytes [20,29,43,48]. Such asym-
metric activation of the cytoskeleton probably functions
in initiating or imparting directionality to cell locomotion.
These data may also help reconcile differences between
our published data [52] and that of Sullivan et al [47]
regarding formylpeptide receptor distributions on the
surface of PMN . Although both of these studies em-
ployed rabbit peritoneal PMN, substantially different ex-
perimental procedures were employed, and the results
seemed somewhat contradictory. However, we used
nearly saturating concentrations of hexapeptide in our
initial study, resulting in almost uniform distributions of
hexapeptide over the cell surface. The formylpeptide
concentration used by Sullivan et al was not stated but
may well have been subsaturating. Assuming that rabbit
PMN display heterogeneity in binding formylpeptide
similar to that shown here for human PMN, Sullivan et
al may have observed only the binding of high-affinity
receptors over the anterior half of each cell. The remain-
ing low-affinity receptors would not be seen at subsatur-
ating formylpeptide concentrations.
The data presented here may also help explain why
high concentrations of chemotactic factor tend to reduce
rather than stimulate directed locomotion [28,331. At
high concentrations, formylpeptide would bind to high-
and low-affinity receptors over the entire cell surface,
such that PMN could not sense or respond appropriately
to a gradient of chemoattractant. At lower concentra-
tions, a certain proportion of the high-affinity receptors
would be occupied and the low-affinity receptors largely
unoccupied. Since the high-affinity receptors (at least)
are distributed asymmetrically over the cell, they may
promote the sensing of hexapeptide concentration gra-
dients and the subsequent locomotory response. This
apparent asymmetry in hexapeptide receptor binding may
be unique to spontaneously polarized PMN. However, it
seems probable that similar asymmetries will be found in
cells stimulated by specific chemokinetic agents or cells
oriented in chemotactic gradients. We are currently in-
vestigating these possibilities.
In this study, we have shown that rounded human PMN
exhibit both receptor and cellular heterogeneity with re-
spect to the formylpeptide receptor and that sponta-
neously polarized PMN display asymmetric arrays of
these receptors across their cell surfaces. The resulting
asymmetric binding of hexapeptide might stimulate cell
polarization and locomotion by amplifying differences in
concentration gradients across the cell surface. Such
asymmetries might then promote random locomotion or
perpetuate directed locomotion by providing preferred
sites for chemotactic factor binding and, consequently,
local activation of the motile apparatus.
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